Analysis of opposing histone modifications H3K4me3 and H3K27me3 reveals candidate diagnostic biomarkers for TNBC and gene set prediction combination |
Park, Hyoung-Min
(Department of Biochemistry, BK21 Plus and Research Institute for Veterinary Science, School of Veterinary Medicine, Seoul National University)
Kim, HuiSu (Department of Biochemistry, BK21 Plus and Research Institute for Veterinary Science, School of Veterinary Medicine, Seoul National University) Lee, Kang-Hoon (Department of Biochemistry, BK21 Plus and Research Institute for Veterinary Science, School of Veterinary Medicine, Seoul National University) Cho, Je-Yoel (Department of Biochemistry, BK21 Plus and Research Institute for Veterinary Science, School of Veterinary Medicine, Seoul National University) |
1 | Zand B, Previs RA, Zacharias NM et al (2016) Role of Increased n-acetylaspartate Levels in Cancer. J Natl Cancer Inst 108, djv426 DOI |
2 | Sun C, Ban Y, Wang K, Sun Y and Zhao Z (2019) SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2. Oncol Lett 17, 2754-2762 |
3 | Wolf J, Muller-Decker K, Flechtenmacher C et al (2014) An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. Oncogene 33, 4273-4278 DOI |
4 | Ma C, Wang F, Han B et al (2018) SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex. Mol Cancer 17, 78 DOI |
5 | Rahman M, Jackson LK, Johnson WE, Li DY, Bild AH and Piccolo SR (2015) Alternative preprocessing of RNASequencing data in The Cancer Genome Atlas leads to improved analysis results. Bioinformatics 31, 3666-3672 DOI |
6 | Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90 DOI |
7 | O'Brien KM, Cole SR, Tse CK et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16, 6100-6110 DOI |
8 | Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295, 2492-2502 DOI |
9 | Jones PA and Baylin SB (2007) The epigenomics of cancer. Cell 128, 683-692 DOI |
10 | Chen X, Hu H, He L et al (2016) A novel subtype classification and risk of breast cancer by histone modification profiling. Breast Cancer Research and Treatment 157, 267-279 DOI |
11 | Koch CM, Andrews RM, Flicek P et al (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 17, 691-707 DOI |
12 | Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 DOI |
13 | Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45, W98-W102 DOI |
14 | Xi Y, Shi J, Li W et al (2018) Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes. BMC Genomics 19, 150 DOI |
15 | Gomez-Cabrero D, Abugessaisa I, Maier D et al (2014) Data integration in the era of omics: current and future challenges. BMC Syst Biol 8 Suppl 2, I1 DOI |
16 | Chaligne R, Popova T, Mendoza-Parra MA et al (2015) The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer. Genome Res 25, 488-503 DOI |
17 | Perou CM (2011) Molecular stratification of triple-negative breast cancers. Oncologist 16 Suppl 1, 61-70 DOI |
18 | Nebbioso A, Tambaro FP, Dell'Aversana C and Altucci L (2018) Cancer epigenetics: Moving forward. PLoS Genet 14, e1007362 DOI |